Regulatory PathRegulatory requirements compared

Active substances

Ethinylestradiol + Etonogestrel

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
NUVARING VAGINAL RING11.7,2.7 mg,mgVaginal delivery system · Vaginal use1 ImplanterSAR 44.40NCE · PrescriptionORGANONValid
ORNIBEL 0.120 mg / 0.015 mg per 24 Hours11,3.474 mg,mgImplant · Vaginal use1 SachetSAR 31.55Generic · PrescriptionEXELTIS GERMANY GmbHValid
Indications — CHI Daman Drug Formulary

CONTRACEPTION; ENDOMETRIOSIS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
NUVARING0.015MG/24HR;0.12MG/24HRring · vaginalORGANON USA ORGANONPrescription3 Oct 2001
ELURYNG0.015MG/24HR;0.12MG/24HRring · vaginalAMNEALPrescription11 Dec 2019
ETHINYL ESTRADIOL; ETONOGESTREL0.015MG/24HR;0.12MG/24HRring · vaginalTEVA PHARMS USA INCPrescription13 Jan 2021
HALOETTE0.015MG/24HR;0.12MG/24HRring · vaginalDR REDDYS LABS SAPrescription5 Aug 2022
ENILLORING0.015MG/24HR;0.12MG/24HRring · vaginalXIROMEDPrescription29 Jun 2023
VERARING0.015MG/24HR;0.12MG/24HRring · vaginalDR REDDYS LABS SADiscontinued9 Dec 2021

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
HALOETTE025200282.7 MG; 11.7 MGRING (SLOW-RELEASE) · VAGINALSEARCHLIGHT PHARMA INC
NUVARING022531862.6 MG; 11.4 MGRING (SLOW-RELEASE) · VAGINALORGANON CANADA INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACNUVARING VAGINAL RING$155.70283per EA22 Jul 2026
NHS Drug TariffEthinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system£29.703 system1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 22.1.6. Intravaginal contraceptives · core
    Contact with health services for contraceptive management
    Local > Vaginal > vaginal ring: 2.7 mg + 11.7 mg

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.